Call to action: Are you a parent or caregiver of a child with epilepsy? Help researchers at Duke University understand how healthcare providers can best communicate information about Sudden Unexpected […]
Epilepsy Alliance America is proud to be supporting Safe Step Act (HR 2163 / S464) This legislation would provide patients and providers with a clear and transparent appeals process when subject […]
Fireside Chat about Epilepsy Alliance America Epilepsy Alliance America Board members, Jeff Sinsebox and Adeola Sonaike, PhD sit down with Eysz founder, Rachel Kuperman, about their work with Epilepsy Alliance […]
Thanks to the generosity of Dr. Lorna Myers who is donating the royalties of her book, PSYCHOGENIC NON-EPILEPTIC SEIZURES: A GUIDE, Epilepsy Alliance America has established a scholarship program for […]
Epilepsy Alliance America is pleased to announce we have joined as a member of the Alliance for Comprehensive Testing (ACT), or ACT Against COVID. As a member of the alliance, we’re dedicated to educating the […]
The safety and well-being of those in the epilepsy community who were impacted by the widespread devastation caused by Hurricane Ida in both the Gulf region and in the Northeast […]
Epilepsy Alliance America is proud to have joined the International Bureau for Epilepsy (IBE) as an Associate Chapter member. EAA’s participation was ratified at the IBE’s General Assembly meeting on […]
A special promo offer is now available for the EAA Network — a 30% discount off of regular priced Student/Family Caregiver tickets. The discount is available only through this special link. […]
Epidiolex®, a cannabidiol (CBD) oral solution by Greenwich Biosciences, is now indicated for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS) or Tuberous Sclerosis Complex in […]
In January 2020 the World Health Organization (WHO) declared the outbreak in China of a new coronavirus disease, COVID-19, to be a Public Health Emergency of International Concern. WHO stated […]

